Skip to main content
. Author manuscript; available in PMC: 2008 Nov 1.
Published in final edited form as: Vaccine. 2007 Sep 14;25(44):7656–7663. doi: 10.1016/j.vaccine.2007.08.042

Table 4.

Geometric Mean Serum Hemagglutination-Inhibiting (HAI) and Neutralizing (Neut) Antibody Titers Before (Pre) and After (Post) Immunization1

    H13
H33
B3
    HAI Neut HAI Neut HAI Neut
   


Group & Dosage2
No.
Pre
Post
Pre
Post
Pre
Post
Pre
Post
Pre
Post
Pre
Post
Total Group                          
Standard 208 11.0 21.1 14.1 27.5 58.9 97.1 28.9 47.8 15.74 25.6 66.84 132.6
High 206 9.7 36.0 12.8 39.7 50.2 137.8 23.3 65.9 12.8 31.1 44.4 127.6
                           
Prev Vaccine                          
Standard 162 12.3 20.3 16.1 26.5 67.4 99.9 33.4 48.0 18.2 24.5 86.4 129.1
High 159 11.1 31.9 14.4 35.5 54.9 115.8 25.1 55.5 14.7 29.3 54.9 114.8
                           
No Prev Vaccine                          
Standard 46 7.4 24.0 8.9 31.8 36.7 87.8 17.4 47.4 9.4 29.7 27.1 145.5
High 47 6.1 54.4 8.7 58.2 37.1 248.6 18.3 117.2 7.9 37.6 21.7 182.4
1

GMT increase from pre to post is significant (p = <.0001) for each comparison

2

Prev vaccine = previously vaccinated (2 to 5 months earlier); no prev vac = no previous vaccine; standard dosage = 15 µg of each component, high dosage = 60 µg of each component

3

H1 = A/New Caledonia (H1N1), H3 = A/Wyoming (H3N2) for HAI, and A/Fuijan (H3N2) for neut, B = B/Jilin

4

Significantly higher than for high dosage

Note: High dose statistically significantly greater for all dose comparisons except for B neut in not previously vaccinated (see text)